US 2010/0063017 A1Published application

Ophthalmic Suspension for Ocular Use

OwnerKothanda Raman T. Rajaninventor

Life of this patent

Estimating the term…

Abstract

A gatifloxacin and prednisolone topical ophthalmic pharmaceutical compositions for prevention and treatment of ophthalmic bacterial infections and inflammatory conditions associated with pre-surgical and/or post surgical ocular surgeries.

Claims20

Dependent claims

1) A topical ophthalmic composition for treating or preventing ophthalmic bacterial infections in a human patient wherein the ophthalmic composition contains gatifloxacin and prednisolone.

Dependencies are inferred from the claim text.

Facts

Application: 12/554,514Filed 4 Sep 2009
Priority: 9 Sep 2008
Published: 11 Mar 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/57
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: substituted in position 17 beta by a chain…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…

Family

Application61/095,452Us provisional application · filed 9 Sep 2008
US 2010/0063017 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results